The Urologic Oncology Fellowship at IU Simon Comprehensive Cancer Center and IU School of Medicine is a two-year program comprised of one research year followed by one year of clinical fellowship.
Our strengths are oncology, minimally invasive surgery, and urinary reconstruction. Fellows participate in advanced surgical training, multidisciplinary didactics, and clinical/translational research endeavors.
In the lab, fellows have access to databases in testis cancer, bladder cancer, prostate cancer, kidney cancer, and laparoscopic and robotic surgery. In the operating room, teaching faculty have unparalleled experience in complex oncologic and reconstructive surgery and are recognized globally for surgical expertise in testicular and advanced bladder cancer.
Applicants to this fellowship program must be eligible for an unrestricted medical license in Indiana and must have completed an accredited residency in the United States or Canada. This fellowship is part of the Society of Urologic Oncology.
Urologic oncology fellows have the opportunity to travel to Kenya through IU School of Medicine's partnership with Moi University and AMPATH and provide care.
Dr. Ronald Boris, an associate professor of clinical urology, is an internationally-recognized authority on hereditary renal cell carcinoma.
With support from the Walther Cancer Foundation, Dr. Boris partnered with Purdue biochemist W. Andy Tao, PhD, in a unique embedding program to develop a urine test that would enable patients to avoid an invasive, painful biopsy to detect a type of kidney cancer.
For more information about the Urologic Oncology Fellowship Program at IU Simon Comprehensive Cancer Center and IU School of Medicine, contact program director Tim Masterson, MD, at tamaster@iupui.edu or 317-948-7560.
